← SynDRA
SB-216763
SynDRA canonical compound SYN0003956 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GSK3B |
| Mechanism of action | GSK-3 inhibitor |
All known targets
Mechanisms of action (all sources)
- GSK-3 inhibitor
- GSK3A INHIBITOR
- GSK3B INHIBITOR
- glycogen synthase kinase inhibitor
Cross-references
Synonyms
- SB 216763
- SB216763
- 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
- 3-(2,4-dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione
- 1H-Pyrrole-2,5-dione, 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-
- CHEMBL102714
- 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione
- SR-01000076052
- Tocris-1616
- Lopac-S-3442
- AC1L41YI
- Lopac0_000934
- SCHEMBL30251
- MLS001074894
- cid_176158
- BDBM8296
- GTPL8015
- CTK8B4807
- CHEBI:91421
- AOB5004
- SYN1075
- EX-A291
- RefChem:884636
- MFCD09753369
- C19H12Cl2N2O2
- JCSGFHVFHSKIJH-UHFFFAOYSA-N
- orb1304564
- SCHEMBL29358424
- SCHEMBL29361308
- GLXC-06773
- HMS2235H21
- HMS3244K13
- HMS3244K14
- HMS3244L13
- HMS3262L10
- HMS3268I05
- HMS3295K21
- HMS3373J13
- HMS3412N05
Look up SB-216763 in the interactive SynDRA portal →